Cargando…

Validation of the 2020 AHA/ACC Risk Stratification for Sudden Cardiac Death in Chinese Patients With Hypertrophic Cardiomyopathy

Background: Sudden cardiac death (SCD) is a common cause of death in hypertrophic cardiomyopathy (HCM), but identification of patients at a high risk of SCD is challenging. The study aimed to validate the three SCD risk stratifications recommended by the 2011 ACCF/AHA guideline, the 2014 ESC guideli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dong, Yan, Yang, Wen, Chen, Chongchong, Ji, Jiamei, Zheng, Wei, Zhang, Fengxiang, Yang, Bing, Li, Xiaorong, Zhou, Xiujuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8415905/ https://www.ncbi.nlm.nih.gov/pubmed/34485400 http://dx.doi.org/10.3389/fcvm.2021.691653

Ejemplares similares

Hypertrophic cardiomyopathy: Sudden cardiac death risk stratification in adults
por: Jordà, Paloma, et al.
Publicado: (2018)

Ventricular arrhythmia and sudden cardiac death in hypertrophic cardiomyopathy: From bench to bedside
por: Shen, Hua, et al.
Publicado: (2022)

The role of the electrocardiographic phenotype in risk stratification for sudden cardiac death in childhood hypertrophic cardiomyopathy
por: Norrish, Gabrielle, et al.
Publicado: (2021)

Prevention of Sudden Death in Hypertrophic Cardiomyopathy
por: Arteaga-Fernández, Edmundo, et al.
Publicado: (2018)

Radiomics Analysis Derived From LGE-MRI Predict Sudden Cardiac Death in Participants With Hypertrophic Cardiomyopathy
por: Wang, Jie, et al.
Publicado: (2021)

Incremental Values of T1 Mapping in the Prediction of Sudden Cardiac Death Risk in Hypertrophic Cardiomyopathy: A Comparison With Two Guidelines
por: Qin, Le, et al.
Publicado: (2021)

Analysis of risk stratification and prevention of sudden death in pediatric patients with hypertrophic cardiomyopathy: Dilemmas and clarity
por: Bonaventura, Jiri, et al.
Publicado: (2023)

Stage 1 hypertension defined by the 2017 ACC/AHA guideline predicts future cardiovascular events in elderly Chinese individuals
por: Xie, Yanxia, et al.
Publicado: (2019)

Similarities in Hypertension Status but Differences in Mortality Risk: A Comparison of 2017 ACC/AHA and 2018 Chinese Hypertension Guidelines
por: Chen, Kangyu, et al.
Publicado: (2022)

Cardiac Magnetic Resonance Scar Imaging for Sudden Cardiac Death Risk Stratification in Patients with Non-Ischemic Cardiomyopathy
por: Kim, Eun Kyoung, et al.
Publicado: (2015)

Late gadolinium enhancement is compatible with advanced age in hypertrophic cardiomyopathy: implications for risk stratification of sudden death
por: Chan, Raymond H, et al.
Publicado: (2012)

Late gadolinium enhancement cardiovascular magnetic resonance for sudden cardiac death risk stratification in hypertrophic cardiomyopathy
por: Ismail, Tevfik F, et al.
Publicado: (2013)

Risk factors of sudden cardiac death in hypertrophic cardiomyopathy
por: Hong, Ying, et al.
Publicado: (2022)

Defying the Odds of Sudden Cardiac Death in Hypertrophic Cardiomyopathy
por: Rostomian, Ara H., et al.
Publicado: (2020)

Differing strategies for sudden death prevention in hypertrophic cardiomyopathy
por: Maron, Martin S, et al.
Publicado: (2023)

AHA/ACC/Multisociety Cholesterol Guidelines: highlights
por: Jialal, Ishwarlal, et al.
Publicado: (2019)

Advanced imaging for risk stratification for ventricular arrhythmias and sudden cardiac death
por: Xie, Eric, et al.
Publicado: (2022)

A validation study of the European Society of Cardiology guidelines for risk stratification of sudden cardiac death in childhood hypertrophic cardiomyopathy
por: Norrish, Gabrielle, et al.
Publicado: (2019)

Electrical storm in hypertrophic cardiomyopathy: Cardiac magnetic resonance and sudden cardiac death risk stratification: a case report
por: Garcia Brás, Pedro, et al.
Publicado: (2023)

The Association of Stage 1 Hypertension, Defined by the 2017 ACC/AHA Guidelines, With Cardiovascular Events Among Rural Women in Liaoning Province, China
por: Wu, Jiake, et al.
Publicado: (2021)

Comparison of ESC and ACC/AHA guidelines for myocardial revascularization
por: Stirrup, Jim, et al.
Publicado: (2017)

Representation of cardiovascular magnetic resonance in the AHA / ACC guidelines
por: von Knobelsdorff-Brenkenhoff, Florian, et al.
Publicado: (2017)

Risk stratification in hypertrophic cardiomyopathy
por: Desai, Milind, et al.
Publicado: (2019)

Hypertension prevalence alteration in 92 815 nurses based on the new standard by 2017 ACC/AHA hypertension guideline: observational cross-sectional study from China
por: Zhao, Bin, et al.
Publicado: (2019)

Incorporation of Retinal Arteriolosclerosis into Risk Stratification of Blood Pressure Category According to the 2017 ACC/AHA Blood Pressure Guideline
por: Matsuoka, Satoshi, et al.
Publicado: (2022)

2013 ACC/AHA Cholesterol Guideline and Implications for Healthy People 2020 Cardiovascular Disease Prevention Goals
Publicado: (2016)

2013 ACC/AHA Cholesterol Guideline and Implications for Healthy People 2020 Cardiovascular Disease Prevention Goals
por: Egan, Brent M., et al.
Publicado: (2016)

MitraClip for Secondary Mitral Regurgitation: Approach to the 2020 ACC/AHA Valvular Heart Disease Guidelines
por: McCauley, Brian D., et al.
Publicado: (2020)

Subclinical Coronary Atherosclerosis: Implication of Coronary Computed Tomography Angiography Findings among Statin Candidates according to the 2013 ACC/AHA Cholesterol Management Guidelines
por: Seo, Jiwoon, et al.
Publicado: (2019)

Incident cerebral microbleeds and hypertension defined by the 2017 ACC/AHA Guidelines
por: Xia, Yiwei, et al.
Publicado: (2021)

Management of the ACC/AHA Stage D Patient: Cardiac Transplantation
por: Kittleson, Michelle M., et al.
Publicado: (2014)

Risk Stratification for Sudden Cardiac Death in Non-Ischaemic Dilated Cardiomyopathy
por: Akhtar, M., et al.
Publicado: (2019)

Risk stratification in childhood hypertrophic cardiomyopathy
por: Norrish, Gabrielle, et al.
Publicado: (2018)

Electrocardiographic amplitudes: a new risk factor for sudden death in hypertrophic cardiomyopathy
por: Östman-Smith, Ingegerd, et al.
Publicado: (2010)

Prevention of Sudden Cardiac Death in Hypertrophic Cardiomyopathy: What has Changed in The Guidelines?
por: Reis, Liliana, et al.
Publicado: (2018)

Consumption and market share of cholesterol-lowering drugs in high-risk patients before and after the release of the 2013 ACC/AHA cholesterol guidelines: a retrospective observational study
por: Kuo, Tzu-Tsen, et al.
Publicado: (2020)

Change in blood pressure status defined by 2017 ACC/AHA hypertension guideline and risk of cardiovascular disease: results of over a decade of follow-up of the Iranian population
por: Kabootari, Maryam, et al.
Publicado: (2023)

Risk Stratification for Sudden Cardiac Death In Patients With Non-ischemic Dilated Cardiomyopathy
por: Shekha, Karthik, et al.
Publicado: (2005)

Machine Learning Outperforms ACC/AHA CVD Risk Calculator in MESA
por: Kakadiaris, Ioannis A., et al.
Publicado: (2018)

Are the guidelines of the ISH devoted to a population not contemplated in the ACC/AHA guidelines?
por: Ruilope, Luis M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8dokt6q72veh3674fa9cgvb5ne